New Opportunities for Diabetes Mellitus Treatment

Main Article Content

N.O. Kravchun
I.P. Romanova
T.M. Tykhonova
I.V. Chernyavska
O.O. Gasanova

Abstract

The paper presents the results of the study of the efficiency and safety of the insulins Insuman® Rapid, Insuman® Basal, Insuman® Comb 25 in patients with type 2 diabetes mellitus. Those medications were found to have high hypoglycemic activity in combination with hypoglycemic tablets. The medications have a good tolerance and are safe.

Article Details

How to Cite
Kravchun, N., I. Romanova, T. Tykhonova, I. Chernyavska, and O. Gasanova. “New Opportunities for Diabetes Mellitus Treatment”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 6.54, Aug. 2013, pp. 77-79, doi:10.22141/2224-0721.6.54.2013.84641.
Section
To practicing Endocrinologists

References

Мищенко Н. Санофи в партнерстве с компанией «Фарма Лайф» запустили производство инсулина Инсуман в Украине [Текст] / Н. Мищенко // Здоров’я України. — 2011. — № 2. — С. 28-29.

Kozak B.M. International Diabetes Federation (IDF) highlights growing global impact of diabetes in 5th edition of the Diabetes Atlas [Text] / B.M. Kozak, M.Y. Tjota, K.L. Close // Journal of Diabetes. — 2012. — Vol. 4. — P. 8-17.

Чернобров А.Д. Довідник основних показників діяльності ендокринологічної служби України за 2012 рік [Текст] / А.Д. Чернобров // Ендокринологія. — 2013. — Т. 18, № 1. — 36 с.

Кушнарева Н.Н. Опыт использования инсулина Инсуман® Базал и Инсуман® Комб 25 в лечении больных сахарным диабетом 2-го типа [Текст] / Н.Н. Кушнарева, В.В. Корпачев, А.В. Ковальчук // Міжнарод. ендокринол. журнал. — 2012. — № 7(47). — С. 77-81.

Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy (InsumanC25CN).

Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes (SPIRIT). Verified September 2012 by Sanofi Aventis.

Laubach E. Neutral protamine Hagedorn insulin [Text] / E. Laubach, P. Schwandt, M.M. Ritter // Lancet. — 2000. — Vol. 355. — P. 236.

NPH insulin administrationby means of a pen injector [Text] / J.O. Jorgensen, A. Flyvbjerg, J.T. Jorgensen [et al.] // Diabet. Med. — 1998. — Vol. 55. — P. 574-576.

Fisken R.A. Treatment of insulin-dependent diabetes using an injection pen: control, problems and patients preferences [Text] / R.A. Fisken, J. Goulbourn // Diabetes Res. — 1989. — Vol. 11. — P. 195-197.